AEGLEA BIOTHERAPEUTICS INC's ticker is AGLE and the CUSIP is 00773J103. A total of 85 filers reported holding AEGLEA BIOTHERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $409,000 | +105.5% | 178,016 | +324.0% | 0.00% | – |
| Q4 2021 | $199,000 | -44.6% | 41,983 | -6.9% | 0.00% | – |
| Q3 2021 | $359,000 | +55.4% | 45,106 | +36.1% | 0.00% | – |
| Q2 2021 | $231,000 | +9.5% | 33,148 | +24.7% | 0.00% | – |
| Q1 2021 | $211,000 | +1.4% | 26,590 | +0.6% | 0.00% | – |
| Q4 2020 | $208,000 | +16.2% | 26,442 | +4.7% | 0.00% | – |
| Q3 2020 | $179,000 | -35.8% | 25,252 | -16.1% | 0.00% | – |
| Q2 2020 | $279,000 | +206.6% | 30,113 | +167.6% | 0.00% | – |
| Q1 2019 | $91,000 | – | 11,251 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Yu Fan | 112,044 | $532,000 | 6.17% |
| Aisling Capital Management LP | 1,691,151 | $8,033,000 | 2.83% |
| Bain Capital Life Sciences Investors, LLC | 2,847,689 | $13,527,000 | 1.07% |
| GREAT POINT PARTNERS LLC | 910,251 | $4,324,000 | 0.96% |
| Samsara BioCapital, LLC | 883,720 | $4,198,000 | 0.81% |
| Sio Capital Management, LLC | 498,500 | $2,368,000 | 0.71% |
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 245,678 | $1,167,000 | 0.53% |
| Nantahala Capital Management | 2,813,560 | $13,364,000 | 0.47% |
| Altium Capital Management LP | 293,764 | $1,395,000 | 0.38% |
| Lion Point Capital, LP | 300,000 | $1,425,000 | 0.38% |